Trials / Completed
CompletedNCT02708459
Transversus Abdominus Plane Block in Living Donor Hepatectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- AlRefaey Kandeel · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug
Detailed description
Transversus abdominus plane block for postoperative analgesia after donor hpatectomy surgery using three different drugs control group, Bupivecaine group, and Dexmedetomedine group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | surgically inserted Transversus abdominus plane catheter | at end of surgery, a surgeon will insert catheter in Transversus abdominus plane (TAP) between internal oblique muscle and Transversus abdominus muscle |
| DRUG | Intravenous morphine | Boluses of intravenous morphine (2 mg) will be given to patients if Visual analogue scale (VAS) more than 3 |
| DRUG | Bupevecaine | |
| DRUG | Dexmedetomedine |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2016-03-15
- Last updated
- 2016-08-30
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02708459. Inclusion in this directory is not an endorsement.